|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 31/573 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/06 | (2018.01) | ||
| A61F 9/00 | (2006.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61K 31/436 | (2006.01) | ||
| A61K 31/56 | (2006.01) | ||
| A61K 47/34 | (2013.01) | ||
| A61K 31/573 | (2006.01) | ||
| A61M2005/3267 | (2013.01) | ||
| A61K 31/7052 | (2006.01) | ||
| A61K 47/32 | (2013.01) | ||
| A61K 31/7105 | (2006.01) | ||
| A61K 9/0051 | (2013.01) | ||
| A61K 47/32 | (2006.01) | ||
| A61F 9/0017 | (2013.01) | ||
| A61K 47/34 | (2017.01) | ||
| A61K 9/1647 | (2013.01) | ||
| A61K 31/7105 | (2013.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61K 31/7052 | (2013.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 27/06 | (2006.01) | ||
| A61K 31/56 | (2013.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61K 31/436 | (2013.01) | ||
| A61P 31/00 | (2006.01) | ||
| A61P 31/00 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61M 5/32 | (2006.01) | ||
| A61P 29/00 | (2018.01) |
| (11) | Number of the document | 3193829 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15771549.1 |
| Date of filing the European patent application | 2015-09-18 | |
| (97) | Date of publication of the European application | 2017-07-26 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/071522 |
| Date | 2015-09-18 |
| (87) | Number | WO 2016/042163 |
| Date | 2016-03-24 |
| (30) | Number | Date | Country code |
| 201462052969 P | 2014-09-19 | US |
| (72) |
YAMAMOTO, Ronald K. , US
CONSTON, Stanley R. , US
NGUYEN, Tien , US
|
| (73) |
Oxular Limited ,
Magdalen Centre
1 Robert Robinson Avenue, Oxford OX4 4GA,
GB
|
| (54) | OPHTHALMIC DRUG COMPOSITIONS |
| OPHTHALMIC DRUG COMPOSITIONS |